pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
pharmadog news

Browse

1,937 stories matching this filter · ← front page

★ save view↓export CSV
rangeto
sort
recentoldestsourcealpha
source
STAT1212Endpoints919BioPharma Dive354BioSpace335Fierce Biotech316onclive165raps111globenewswire health
therapy area
allOncology8159Rare Disease1937Cardiology1879Immunology1565Hematology1354Pulmonology1264Vaccines
  • Esther Wojcicki launches AI healthcare residency to aid startup co-founder collaboration
    Esther Wojcicki, often called the godmother of Silicon Valley, is turning her attention to health technology education. She is helping to launch a new AI healthcare residency program aimed at early…
    Endpoints · 4mo agoPositive↗ source
  • Amgen Announces Retirement of Chief Technology Officer David Reese
    Amgen announced that longtime leader David Reese will retire at the end of June. Reese, 63, currently serves as the company's chief technology officer, a position he created in 2023 after many yea…
    Endpoints · 4mo agoNeutral↗ source
← prev
page 78 of 78
next →
73
fda recalls72
fda medwatch62
fda press38
1262
Psychiatry & CNS889
Ophthalmology521
Pain503
Endocrinology & Metabolism495
Infectious Disease457
Revolution Medicines' early-stage pancreatic cancer drug shows tumor control in half of patients
Revolution Medicines reported that its experimental therapy daraxonrasib helped control tumors in at least half of patients with early-stage pancreatic cancer, whether given alone or with chemother…
BioPharma Dive · 4mo agoPositive readoutPositive↗ source
  • Moderna launches Phase 3 trial of mRNA bird flu vaccine after US funding cut
    Moderna has begun enrolling participants in a Phase 3 trial of its mRNA-1018 vaccine targeting H5 influenza (bird flu). The trial aims to include about 4,000 healthy adults in the United States and…
    BioPharma Dive · 4mo agoPositive↗ source
  • AbbVie allocates $1.4 billion for new 185-acre manufacturing campus in Durham, NC
    AbbVie has disclosed more details of its $100 billion pledge to the United States, setting aside $1.4 billion to build its first manufacturing campus in North Carolina. The project will cover a 18…
    Endpoints · 4mo agoDealNeutral↗ source
  • Merck commits up to $1 billion to Google Cloud partnership to accelerate AI across its operations
    Merck announced a multiyear partnership with Google Cloud, investing up to $1 billion to embed AI tools throughout its research, development, manufacturing, commercial and corporate functions. The…
    BioPharma Dive · 4mo agoDealPositive↗ source
  • Owkin launches autonomous AI scientist to accelerate drug discovery
    A new AI platform from Owkin, called K Pro, is designed to act as an autonomous "AI scientist," handling complex research questions that traditionally require teams of scientists. The system build…
    BioPharma Dive · 4mo agoPositive↗ source
  • OpenAI releases free ChatGPT for Clinicians to assist doctors, nurses and pharmacists
    OpenAI announced the launch of ChatGPT for Clinicians, a free AI‑powered tool designed for use by physicians, nurse practitioners, physician assistants and pharmacists. The service aims to help cl…
    Endpoints · 4mo agoPositive↗ source
  • BridgeBio Oncology appoints CSO Pedro Beltran as CEO, makes Neil Kumar executive chairman
    BridgeBio Oncology Therapeutics announced a leadership reshuffle aimed at strengthening its focus on KRAS-driven cancer programs. The company is replacing CEO Eli Wallace with its chief scientific…
    Endpoints · 4mo agoNeutral↗ source
  • Pharma-backed petition urges FDA to change policy on public release of drug rejection letters
    A law firm representing an unnamed pharmaceutical company has filed a petition asking the FDA to revise its new practice of publishing partially redacted drug rejection letters. The petition argue…
    Endpoints · 4mo agoRegulatoryNegative↗ source
  • Biotech layoff tracker 2026 shows Clinuvel cuts 20% staff, Novartis sheds 322 US jobs
    Fierce Biotech released its fifth annual layoff tracker for 2026, noting that workforce reductions continue to rise in the sector after a year of increasing cuts. The July update lists two compani…
    Fierce Biotech · 8mo agoLayoffsNegative↗ source
  • Biotech fundraising tracker reports $70M Series C for Ratio Therapeutics and $130M Series B for Crystalys Therapeutics
    The Fierce Biotech Fundraising Tracker continues to log only large venture capital rounds, focusing on deals of $50 million or more. Ratio Therapeutics secured a $70 million Series C, backed by in…
    Fierce Biotech · 8mo agoDealNeutral↗ source